COA Endpoint Strategy Lead: Clinical Outcomes Expert

IQVIA; Paris; Sur place; EUR 100 000 - 120 000; Plein temps

Avantages offerts par ce poste

Continuous professional and personal development

Entrepreneurial team environment

Résumé du poste

IQVIA is seeking an Associate Principal/Principal Clinical Outcome Assessment (COA) Endpoint Strategy expert to lead client engagement and project delivery. This role involves developing COA endpoint strategies, providing scientific leadership in instrument development, and advising on regulatory interactions.

The ideal candidate should have deep expertise in COA measurement with a strong publication record and advanced degrees such as a PhD or MD. This position offers an opportunity to impact patient outcomes significantly.

Qualifications

• Extensive experience developing COA endpoint strategies across therapeutic areas.
• Hands-on experience developing new COA instruments and qualitative validation.
• Strong publication record in outcomes research or COA measurement science.

Responsabilités

• Develop COA endpoint strategies across clinical development programs.
• Advise on development of COA endpoint strategies for regulatory interactions.
• Provide scientific leadership in new COA instruments from concept to validation.

Connaissances

COA types expertise (PRO, ObsRO, ClinRO, PerfO)

Scientific writing skills

Stakeholder engagement

Ability to mentor junior team members

Formation

PhD, MD, PharmD, DrPH, MSc in a relevant scientific discipline

Description du poste

IQVIA is seeking an Associate Principal/Principal Clinical Outcome Assessment (COA) Endpoint Strategy expert to lead client engagement and project delivery. This role involves developing COA endpoint strategies, providing scientific leadership in instrument development, and advising on regulatory interactions.

The ideal candidate should have deep expertise in COA measurement with a strong publication record and advanced degrees such as a PhD or MD. This position offers an opportunity to impact patient outcomes significantly.